TRINITY BIOTECH PLC
For the period ended Aug 28, 2026. Filed Aug 28, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Aug 28, 2026 · Filed Aug 28, 2026
Use the contents to explore the available documents and sections.
Contents
EXPLANATORY NOTE
On August 28, 2026, the Company issued a press release providing an update on its diagnostics business and the continued execution of its transformation strategy. The press release also included a corporate update regarding the Company's Nasdaq listing. A copy of the press release is being filed herewith as Exhibit 99.1
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.